Nike
NYSE: NKE
Nike, Inc. (NKE) is a global sportswear company that designs, markets, and sells athletic footwear, apparel, equipment, and accessories. Its major brands include Nike, Jordan, and Converse. The company sells products through its own retail stores, digital platforms, and wholesale partners worldwide. Investors closely monitor revenue growth, consumer demand, profit margins, inventory levels, and competition in the global sportswear market.
- Sector
- Consumer Non-Durables
- Industry
- Apparel/Footwear
- Employees
- 73,000
- Founded
- 1964
- Website
- nike.com ↗
The forecast figures are tipranks’s, read on 2026-10-25 and linked below.
The company facts and financials are CNN Business’s, read on 2026-11-05 and linked below.
Nike forecast
The forecast in short
tipranks records 36 analyst ratings on Nike and summarises them as “Hold”. Their average 12-month price target is USD 36.58 (Potential Growth = -1.92%). Its tipranks score is 1 out of 10 — Underperform. These are tipranks’s figures as read on 2026-10-25, not CariBroker’s own view, and nothing here is advice to buy or sell.
Market cap
USD 53.93 B
≈ RM 220.61 B
Share price
USD 36.31
≈ RM 148.53 · 18 Nov close
#441World ranking
tipranks score
Underperform
Analyst ratings
Hold
- Buy925%
- Hold1850%
- Sell925%
tipranks’s own summary of the 36 ratings above.
12 months price forecast
USD 36.58 Potential Growth = -1.92%
As tipranks publishes it. CariBroker has not recalculated any of it.
Financials
Q1 earnings, quarter ending Aug 30, 2026
| Measure | Q1 2026 | 1-year change |
|---|---|---|
| Total revenue | 11.22B | 0.52% down |
| Net income | 712.00M | 36.92% up |
| Earnings per share | 0.48 | 2.42% down |
| Net profit margin | 6.35% | 2.39% up |
| Free cash flow | -64.00M | 122.54% down |
| Debt-to-equity ratio | 0.73 | 11.42% down |
Revenue and net income, last 4 quarters
Total revenueNet income
Analyst profiles: who made each call, and when
| Analyst | From | Position | Target price | Dated |
|---|---|---|---|---|
| Anna Andreeva | Piper Sandler | Hold | USD 28 | 2026-10-22 |
| Ashley Owens | KeyBanc | Hold | N/A | 2026-10-22 |
| Aneesha Sherman | Bernstein | Buy | USD 45 | 2026-10-22 |
| Matthew Boss | J.P. Morgan | Sell | USD 33 | 2026-10-22 |
| Adrienne Yih | Barclays | Buy | USD 45 | 2026-10-22 |
Show all 36
| Analyst | From | Position | Target price | Dated |
|---|---|---|---|---|
| Spencer Hanus | Wolfe Research | Sell | USD 28 | 2026-10-21 |
| Lorraine Hutchinson | Bank of America Securities | Sell | USD 24 | 2026-10-21 |
| Robert Drbul | BTIG | Buy | USD 50 | 2026-10-21 |
| Christine Dooley | Argus Research | Buy | USD 42 | 2026-10-16 |
| Nick Anderson CFA | Berenberg Bank | Sell | USD 27.5 | 2026-10-14 |
| Jay Sole | UBS | Hold | N/A | 2026-10-13 |
| Krisztina Katai | Deutsche Bank | Hold | USD 33 | 2026-10-09 |
| Cristina Fernandez | Telsey Advisory | Hold | USD 35 | 2026-10-06 |
| Peter McGoldrick | Stifel Nicolaus | Hold | USD 36 | 2026-10-05 |
| Paul Lejuez | Citi | Hold | USD 32 | 2026-10-05 |
| Piral Dadhania | RBC Capital | Hold | USD 40 | 2026-10-02 |
| Joseph Civello | Truist Financial | Hold | USD 29 | 2026-10-02 |
| Katharina Schmenger | DZ BANK AG | Sell | N/A | 2026-10-02 |
| Ike Boruchow | Wells Fargo | Hold | USD 30 | 2026-10-02 |
| Georgy Vashchenko | Freedom Capital Markets | Buy | USD 51 | 2026-10-02 |
| Randal Konik | Jefferies | Buy | USD 60 | 2026-10-02 |
| Kelly Crago | BMO Capital | Sell | USD 25 | 2026-10-02 |
| Laurent Vasilescu | Exane BNP Paribas | Sell | USD 19 | 2026-10-02 |
| Zachary Warring | CFRA | Buy | USD 62 | 2026-10-02 |
| Alexandra Straton | Morgan Stanley | Sell | USD 27 | 2026-10-02 |
| Tom Nikic | Needham | Hold | N/A | 2026-10-02 |
| Michael Binetti | Evercore ISI | Hold | USD 28 | 2026-10-02 |
| Jonathan Komp | Robert W. Baird | Hold | USD 36 | 2026-10-02 |
| Sam Poser | Williams Trading | Hold | USD 30 | 2026-10-02 |
| Brooke Roach | Goldman Sachs | Hold | USD 30 | 2026-10-01 |
| Simeon Siegel | Guggenheim | Buy | USD 50 | 2026-10-01 |
| Rick Patel | Raymond James | Hold | N/A | 2026-09-29 |
| Akshay Gupta | HSBC | Hold | USD 40 | 2026-09-28 |
| Brian Nagel | Oppenheimer | Buy | USD 52 | 2026-09-28 |
| Unknown Analyst | Bank of China | Sell | USD 30 | 2026-09-25 |
| Alison Fok | DBS | Buy | USD 71 | 2026-03-04 |
Investment strengths
Performance portfolio growth
Broad-based growth across multiple sports demonstrates that Nike still has product innovation, brand relevance, and category depth beyond its challenged lifestyle franchises. Continued gains in Performance can diversify revenue, strengthen consumer engagement, and provide a durable foundation for recovery.
Gross margin and expense discipline
Improving gross margin alongside lower reported SG&A shows that management retains meaningful control over costs despite weaker demand. This discipline can help protect profitability during the transition and preserve resources for product innovation, marketing, and marketplace investments.
Strong balance sheet
A net-cash position and substantial liquidity give Nike flexibility to fund restructuring, sustain strategic investment, and continue shareholder distributions while operating trends recover. This financial resilience reduces dependence on external financing and supports long-term brand and channel initiatives.
People also ask
What is the 12-month price target for Nike (NKE)?
tipranks publishes an average 12-month price target of USD 36.58 (Potential Growth = -1.92%), as read on 2026-10-25. The highest target is USD 62 and the lowest is USD 19. A price target is an analyst’s estimate of where a share might trade, not a promise, and CariBroker gives no investment advice.
How many analysts cover Nike (NKE)?
tipranks records 36 analyst ratings: 9 buy, 18 hold and 9 sell, which it summarises as “Hold”, as read on 2026-10-25.
What is the tipranks score for Nike (NKE)?
tipranks scores it 1 out of 10 and calls that “Underperform”, as read on 2026-10-25. The score is tipranks’s, not CariBroker’s, and CariBroker does not rate listed shares.
Is this CariBroker’s own forecast for Nike?
No. Every figure on this page is published by tipranks, copied on 2026-10-25 with a link to the original, and not recalculated. CariBroker checks financial companies in Malaysia against the public registers; it makes no forecast of its own and holds no licence to advise on securities.
Disclaimer
CariBroker provides information only and does not provide investment, financial or legal advice.
Check another company
Search every bank, broker and alert list in one place
